Second- and third-line treatment of metastatic breast cancer with gemcitabine

被引：9
|
作者：
Brodowicz, T
Möslinger, R
Herscovici, V
Vaclavik, I
Wiltschke, C
Kubista, E
Zielinski, C
机构：
[1] Univ Vienna, Clin Div Oncol, A-1010 Vienna, Austria
[2] Univ Vienna, Chair Med Expt Oncol, A-1010 Vienna, Austria
[3] Univ Vienna, Dept Obstet & Gynaecol, A-1010 Vienna, Austria
[4] Univ Vienna, Dept Internal Med 1, A-1010 Vienna, Austria
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80169-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
180
引用
收藏
页码：S44 / S44
页数：1
相关论文
共 50 条
  • [1] Single-agent gemcitabine as second- and third-line treatment in metastatic breast cancer
    Brodowicz, T
    Kostler, WJ
    Möslinger, R
    Tomek, S
    Vaclavik, I
    Herscovici, V
    Wiltschke, C
    Steger, GG
    Wein, W
    Seifert, M
    Kubista, E
    Zielinski, CC
    BREAST, 2000, 9 (06): : 338 - 342
  • [2] Monotherapy with docetaxel in second- or third-line treatment of anthracycline-resistant metastatic breast cancer
    Brodowicz, T
    Koestler, WJ
    Tomek, S
    Vaclavik, I
    Herscovici, V
    Wiltschke, C
    Steger, GG
    Zielinski, CC
    ANTI-CANCER DRUGS, 2000, 11 (03) : 149 - 153
  • [3] Bevacizumab in the treatment of metastatic colorectal cancer (mCRC) in second- and third-line settings
    Giantonio, Bruce J.
    SEMINARS IN ONCOLOGY, 2006, 33 (05) : S15 - S18
  • [4] Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer
    Jaime Coronel
    Lucely Cetina
    Myrna Candelaria
    Aurora González-Fierro
    Daimy Arias
    David Cantu
    Alfonso Dueñas-González
    Medical Oncology, 2009, 26 : 210 - 214
  • [5] Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer
    Coronel, Jaime
    Cetina, Lucely
    Candelaria, Myrna
    Gonzalez-Fierro, Aurora
    Arias, Daimy
    Cantu, David
    Duenas-Gonzalez, Alfonso
    MEDICAL ONCOLOGY, 2009, 26 (02) : 210 - 214
  • [6] Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma
    Zauderer, Marjorie G.
    Kass, Samantha L.
    Woo, Kaitlin
    Sima, Camelia S.
    Ginsberg, Michelle S.
    Krug, Lee M.
    LUNG CANCER, 2014, 84 (03) : 271 - 274
  • [7] Second- or third-line chemotherapy in NSCLC
    Sorensen, JB
    LUNG CANCER, 2004, 45 : S18 - S18
  • [8] Second- and third-line treatment for pediatric patients failing ART
    Giaquinto, C.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 68 - 68
  • [9] FOLFIRI regimen as second- and third-line chemotherapy for metastatic biliary tract or pancreatic cancer.
    Loioia, Fernanda Navarro
    Guedes Camandaroba, Marcos Pedro
    Oliveira Fernandes, Viviane Teodoro
    Rodrigues Pereira, Augusto Akikubo
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Bi-weekly Paclitaxel and Capecitabine as a Second- or Third-line Treatment for Advanced Breast Cancer: A Pilot Study
    Kellokumpu-Lehtinen, Pirkko-Liiisa
    Tuunanen, Tuija
    Kautio, Anna-Liisa
    Lehtinen, Ilari
    Tanner, Minna
    ANTICANCER RESEARCH, 2013, 33 (11) : 4941 - 4945
12345